Literature DB >> 7804958

Anti-Ro(SSA) and anti-La(SSB) antibodies in autoimmune rheumatic diseases.

P Youinou1, Y Adler, S Muller, A Lamour, D Baron, R L Humbel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7804958     DOI: 10.1007/BF02802321

Source DB:  PubMed          Journal:  Clin Rev Allergy        ISSN: 0731-8235


× No keyword cloud information.
  99 in total

1.  Influence of helical organization on immunogenicity and antigenicity of synthetic peptides.

Authors:  H Gras-Masse; M Jolivet; H Drobecq; J P Aubert; E H Beachey; F Audibert; L Chedid; A Tartar
Journal:  Mol Immunol       Date:  1988-07       Impact factor: 4.407

2.  Heterologous expression and epitope mapping of a human small nuclear ribonucleoprotein-associated Sm-B'/B autoantigen.

Authors:  L A Rokeach; M Jannatipour; S O Hoch
Journal:  J Immunol       Date:  1990-02-01       Impact factor: 5.422

Review 3.  Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine.

Authors:  E M Tan
Journal:  Adv Immunol       Date:  1982       Impact factor: 3.543

Review 4.  Antinuclear antibody profiles in relation to specific disease manifestations of systemic lupus erythematosus.

Authors:  A J Swaak; V Huysen; J C Nossent; R J Smeenk
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

Review 5.  Antinuclear antibodies in autoimmune disease. Significance and pathogenicity.

Authors:  C E Harmon
Journal:  Med Clin North Am       Date:  1985-05       Impact factor: 5.456

6.  Enhanced membrane binding of autoantibodies to cultured keratinocytes of systemic lupus erythematosus patients after ultraviolet B/ultraviolet A irradiation.

Authors:  T D Golan; K B Elkon; A E Gharavi; J G Krueger
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

Review 7.  Autoantibodies and their relation to rheumatic diseases.

Authors:  G A McCarty
Journal:  Med Clin North Am       Date:  1986-03       Impact factor: 5.456

8.  Anti La(SSB) identifies a distinctive subgroup of systemic lupus erythematosus.

Authors:  P J Maddison; D A Isenberg; N J Goulding; J Leddy; R P Skinner
Journal:  Br J Rheumatol       Date:  1988-02

9.  Ro/SSA inhibits the autologous mixed lymphocyte reaction.

Authors:  J Karsh; J B Harley; R Goldstein; A I Lazarovits
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

10.  A major part of the polypeptide chain of tobacco mosaic virus protein is antigenic.

Authors:  Z A Moudallal; J P Briand; M H Regenmortel
Journal:  EMBO J       Date:  1985-05       Impact factor: 11.598

View more
  2 in total

1.  RNA chaperone activity of protein components of human Ro RNPs.

Authors:  Aurélia Belisova; Katharina Semrad; Oliver Mayer; Grazia Kocian; Elisabeth Waigmann; Renée Schroeder; Günter Steiner
Journal:  RNA       Date:  2005-05-31       Impact factor: 4.942

2.  The levels of the RoRNP-associated Y RNA are dependent upon the presence of ROP-1, the Caenorhabditis elegans Ro60 protein.

Authors:  J C Labbé; S Hekimi; L A Rokeach
Journal:  Genetics       Date:  1999-01       Impact factor: 4.562

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.